logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
S

Seiichiro Mitani

faculty of medicine
H指数:15
被引数:787

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A prospective observational study of treatment sequencing with regorafenib and FTD/TPI in metastatic colorectal cancer: The OSERO study

奥塞罗研究：一项关于regorafenib和FTD/TPI在转移性结直肠癌中治疗顺序的前瞻性观察研究

British Journal of Cancer
IF6.8
2026-09-290
PRE
Takeshi Kawakami; Toshiki Masuishi; Tetsutaro Hamano; Akihiko Chida; Seiichiro Mitani; Hisateru Yasui; Atsushi Ishiguro; Takayuki Ando; Kentaro Sawada; Kazuaki Harada; Naoki Takahashi; Shogen Boku; Tomomi Kashiwada; Taito Esaki; Ayumu Yoshikawa; Keiji Sugiyama; Kouji Yamamoto; Hironaga Satake; Satoshi Yuki; Kentaro Yamazaki; Eiji Oki
Phase II study of mFOLFOX6 in advanced gastric cancer patients with severe peritoneal metastases (WJOG10517G), including an individual patient data comparison with JCOG1108/WJOG7312G

晚期胃癌伴严重腹膜转移患者mFOLFOX6方案的II期研究（WJOG10517G），包括与JCOG1108/WJOG7312G的个体患者数据比较

Gastric Cancer
IF5.1
2026-08-270
OAAI
Toshiki Masuishi; Hiroki Hara; Takayuki Ando; Takeshi Kawakami; Yoshiyuki Yamamoto; Naotoshi Sugimoto; Kazuhiro Shiraishi; Taito Esaki; Yuji Negoro; Takao Tsuzuki; Hiroaki Sawai; Masato Nakamura; Takashi Inagaki; Yudai Shinohara; Kentaro Kawakami; Seiichiro Mitani; Kenji Tsuchihashi; Chihiro Kondoh; Hiroo Katsuya; Osamu Maeda; Yuriko Fujita; Kenichi Yoshimura; Masanori Terashima; Takako Eguchi Nakajima; Kei Muro
Trifluridine/tipiracil with or without bevacizumab in microsatellite instability-high/mismatch repair-deficient metastatic colorectal cancer: A retrospective observational study

三氟尿idine/替吡拉塞与或不与贝伐珠单抗联用治疗微卫星不稳定性高/错配修复缺陷型转移性结直肠癌：一项回顾性观察性研究

Therapeutic Advances in Medical Oncology
IF4.2
2026-08-060
PRE
Hiroko Hasegawa; Rin Inamoto; Keiji Sugiyama; Naoki Izawa; Seiichiro Mitani; Takeshi Kawakami; Satoshi Yuki; Hidekazu Hirano; Saori Mishima; Tetsutaro Hamano; Toshiki Masuishi
Randomized phase II study of FOLFIRI plus ramucirumab versus FOLFOXIRI plus ramucirumab as first-line treatment for metastatic colorectal cancer: WJOG9216G (RECAST)

随机对照II期研究：FOLFIRI联合ramucirumab与FOLFOXIRI联合ramucirumab作为转移性结直肠癌一线治疗的比较：WJOG9216G（RECAST）

European Journal of Cancer
IF7.1
2026-03-190
OAAI
Yosuke Kito; Kentaro Yamazaki; Hirokazu Shoji; Takeshi Yamada; Takahiro Tsushima; Seiichiro Mitani; Kazuhiro Shiraishi; Hisateru Yasui; Hiroki Hara; Kenro Hirata; Taito Esaki; Yudai Shinohara; Takao Tsuzuki; Shinya Kajiura; Toshiki Masuishi; Naoki Izawa; Eishi Baba; Kohei Murata; Naoya Akazawa; Yozo Suzuki
Ramucirumab-containing chemotherapy for patients with gastrointestinal neuroendocrine carcinoma refractory/intolerant to platinum-based chemotherapy: A multicenter observational retrospective study (WJOG13420G)

含Ramucirumab的化疗方案用于对铂类为基础的化疗方案耐药/不耐受的胃肠道神经内分泌癌患者的疗效：一项多中心观察性回顾研究（WJOG13420G）

International Journal of Cancer
IF4.7
2025-07-230
OAAI
Yuki Matsubara; Toshiki Masuishi; Waki Hosoda; Hidekazu Hirano; Saori Mishima; Hiroyuki Takahashi; Tomoyuki Otsuka; Kenta Kawasaki; Takeshi Kawakami; Kazuhiro Yanagihara; Takaya Shimura; Masato Komoda; Kozue Murayama; Keiko Minashi; Yoshiyuki Yamamoto; Yudai Shinohara; Shinichi Nishina; Nobuyuki Musha; Kyoko Kato; Kentaro Kawakami; Katsunori Shinozaki; Kenji Tsuchihashi; Takayuki Ando; Yosuke Kito; Akitaka Makiyama; Seiichiro Mitani; Kaori Hino; Naoki Izawa; Isao Oze; Kei Muro
A multicenter, prospective, observational study of nivolumab readministration for advanced gastric cancer (NIVO RETURNS)

一项关于纳武利尤单抗再给药用于晚期胃癌的多中心、前瞻性、观察性研究（NIVO RETURNS）

FUTURE ONCOLOGY
IF2.6
2025-05-080
PRE
Kodama, Hiroyuki; Narita, Yukiya; Nakamura, Michio; Takahashi, Masanobu; Mizukami, Takuro; Ando, Takayuki; Mitani, Seiichiro; Komori, Azusa; Hosokawa, Ayumu; Sugiyama, Keiji; Taguri, Masataka; Orihara, Shunichiro; Kagamu, Hiroshi; Yamaguchi, Toshifumi; Nishikawa, Hiroki; Muro, Kei
The efficacy and safety of FOLFOX therapy for advanced esophageal squamous cell carcinoma

FOLFOX治疗晚期食管鳞癌的疗效和安全性

SCIENTIFIC REPORTS
IF3.9
2025-03-070
OAAI
Shiraishi, Kazuhiro; Okada, Mao; Yamamoto, Shun; Matsubara, Yuki; Masuishi, Toshiki; Shimozaki, Keitaro; Yamamoto, Yoshiyuki; Hirose, Suguru; Sugiyama, Keiji; Furuta, Mitsuhiro; Machida, Nozomu; Takahashi, Naoki; Yoshii, Takako; Kito, Yosuke; Tsuzuki, Takao; Boku, Shogen; Tsuchihashi, Kenji; Sugaya, Akinori; Takayama, Toshizo; Komori, Azusa; Mitani, Seiichiro; Matsumoto, Toshihiko; Nishimura, Takashi; Hirata, Kenro
Prevalence and clinicopathological features of microsatellite instability-high metastatic or recurrent gastric and esophagogastric junction cancer: WJOG13320GPS

WJOG13320GPS: 微卫星不稳定性高转移性或复发性胃癌和食管胃结合部癌的患病率和临床病理特征

GASTRIC CANCER
IF5.1
2024-12-310
PRE
Komori, Azusa; Hironaka, Shuichi; Kadowaki, Shigenori; Mitani, Seiichiro; Furuta, Mitsuhiro; Kawakami, Takeshi; Makiyama, Akitaka; Takegawa, Naoki; Sugiyama, Keiji; Hirano, Hidekazu; Ando, Takayuki; Matsushima, Tomohiro; Chida, Akihiko; Kashiwada, Tomomi; Komoda, Masato; Matsumoto, Toshihiko; Oda, Hisanobu; Yabusaki, Hiroshi; Kawakami, Hisato; Yamazaki, Kentaro; Boku, Narikazu; Hyodo, Ichinosuke; Yoshimura, Kenichi; Muro, Kei
Update analysis of the randomized phase II study comparing FOLFIRI plus ramucirumab (RAM) versus FOLFOXIRI plus RAM as first-line treatment for patients with metastatic colorectal cancer: WJOG9216G (RECAST)

对比较FOLFIRI联合ramucirumab（RAM）与FOLFOXIRI联合RAM作为转移性结直肠癌患者一线治疗的随机II期研究的更新分析：WJOG9216G（RECAST）

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Yamazaki, K.; Kito, Y.; Shoji, H.; Yamada, T.; Tsushima, T.; Mitani, S.; Shiraishi, K.; Yasui, H.; Hara, H.; Shimozaki, K.; Esaki, T.; Shinohara, Y.; Tsuzuki, T.; Kajiura, S.; Yoshimura, K.; Sakai, K.; Nishio, K.; Kawakami, H.; Hironaka, S.; Muro, K.
Impact of age and single heterozygous UGT1A1 on the safety and efficacy of first-line FOLFIRI or FOLFOXIRI in combination with ramucirumab (RAM) for metastatic colorectal cancer (mCRC): Subgroup analyses of WJOG9216G (RECAST)

年龄和单杂合UGT1A1对含雷莫芦单抗(RAM)的转移性结直肠癌(mCRC)一线FOLFIRI或FOLFOXIRI方案的安全性和有效性的影响：WJOG9216G (RECAST)的亚组分析

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Shiraishi, K.; Kito, Y.; Shoji, H.; Yamada, T.; Tsushima, T.; Mitani, S.; Yasui, H.; Hara, H.; Shimozaki, K.; Esaki, T.; Shinohara, Y.; Tsuzuki, T.; Kajiura, S.; Izawa, N.; Murata, K.; Yoshimura, K.; Kawakami, H.; Hironaka, S.; Yamazaki, K.; Muro, K.
The combination of soluble forms of PD-1 and PD-L1 as a predictive marker of PD-1 blockade in patients with advanced cancers: a multicenter retrospective study

可溶性PD-1和PD-L1联合作为晚期癌症患者PD-1阻断的预测标志物: 一项多中心回顾性研究

FRONTIERS IN IMMUNOLOGY
IF5.9
2023-12-118
OAAI
Kurosaki, Takashi; Chamoto, Kenji; Suzuki, Shinichiro; Kanemura, Hiroaki; Mitani, Seiichiro; Tanaka, Kaoru; Kawakami, Hisato; Kishimoto, Yo; Haku, Yasuharu; Ito, Katsuhiro; Sato, Toshiyuki; Suminaka, Chihiro; Yamaki, Mami; Chiba, Yasutaka; Yaguchi, Tomonori; Omori, Koichi; Kobayashi, Takashi; Nakagawa, Kazuhiko; Honjo, Tasuku; Hayashi, Hidetoshi

研究方向

暂未获取到该数据
K
Kei Muro
H 指数:80论文数:1,040被引数:4.4万
T
Toshiki Masuishi
H 指数:24论文数:324被引数:3,031
S
Shigenori Kadowaki
H 指数:36论文数:419被引数:6,970
H
Hisato Kawakami
H 指数:43论文数:446被引数:8,790
Y
Yukiya Narita
H 指数:20论文数:198被引数:1,957
S
Shogen Boku
H 指数:10论文数:129被引数:451
Y
Yosuke Kito
H 指数:13论文数:103被引数:673
Y
Yoshiyuki Yamamoto
H 指数:24论文数:263被引数:3,423
T
Takeshi Kawakami
H 指数:11论文数:164被引数:607
K
Kentaro Kawakami
H 指数:10论文数:78被引数:753